Brady Corporation (BRC) - 10-Q Summary
Business Context and Reporting Period
Company: Brady Corporation
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended January 31, 2026
Business Overview: Global manufacturer of identification, direct part marking, high-performance materials, and workplace safety products. Operations are organized into two reportable segments: Americas & Asia and Europe & Australia.
Key Financial Metrics
| Metric (Dollars in Thousands) | Three Months Ended Jan 31, 2026 | Six Months Ended Jan 31, 2026 |
|---|---|---|
| Net Sales | $384,137 | $789,424 |
| Gross Margin | $194,394 (50.6%) | $403,226 (51.1%) |
| Operating Income | $62,190 (16.2%) | $130,162 (16.5%) |
| Net Income | $48,051 | $101,987 |
| Diluted EPS (Class A) | $1.01 | $2.14 |
| Cash from Operating Activities | N/A | $86,670 |
| Long-Term Debt | $78,706 | $78,706 |
| Cash and Equivalents | $176,492 | $176,492 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 7.7% for the quarter and 7.6% for the six-month period compared to the prior year. Growth was driven by organic sales (1.6% Q/Q, 2.2% YTD), acquisitions (2.3% Q/Q, 2.8% YTD), and favorable foreign currency translation (3.8% Q/Q, 2.6% YTD).
- Margin Expansion: Gross margin percentage improved to 50.6% (Q/Q) and 51.1% (YTD) from 49.3% and 49.8% respectively. Improvements were aided by the absence of prior-year facility closure costs and non-recurring acquisition inventory adjustments.
- Operating Expenses: R&D expenses increased significantly (29.8% Q/Q, 26.5% YTD) due to recent acquisitions (Microfluidic Solutions, Mecco) and increased headcount. SG&A expenses increased modestly (1.9% Q/Q, 3.6% YTD) but decreased as a percentage of sales due to prior-year cost reductions.
- Segment Performance:
- Americas & Asia: Organic sales grew 3.1% (Q/Q) and 3.9% (YTD). Segment profit increased 16.9% (Q/Q) and 12.6% (YTD).
- Europe & Australia: Organic sales declined 1.1% (Q/Q) and 0.9% (YTD) due to lower volume in safety and product identification lines. However, segment profit surged 35.5% (Q/Q) and 39.4% (YTD) due to a more efficient cost structure following reorganization.
- Acquisitions: The company acquired MECCO Partners LLC in August 2025 for $19.2 million (net of cash), adding to its direct part marking capabilities.
Guidance, Outlook, and Risks
- Outlook: Management expects to continue investing in organic growth, acquisitions, and R&D. The company aims to maintain profitability through pricing mechanisms to offset inflationary pressures and tariffs.
- Liquidity: The company maintains a $300 million credit agreement with $219.2 million available for future borrowing. Cash balances are sufficient to fund operations, capital expenditures, and shareholder returns for the next 12 months.
- Capital Allocation: The company continues to return capital via dividends ($0.2450 per share for the quarter) and share repurchases ($4.9 million in the quarter; $78.0 million remaining under the current authorization).
- Risks: Key risks include global trade tariffs, supply chain disruptions, raw material costs, foreign currency fluctuations, and the ability to integrate acquired businesses. The company notes that the global trade environment remains complex with potential for additional costs from tariffs.
Investor Verification Checklist
- Organic Growth Sustainability: Verify if the 1.6% organic growth rate is sustainable given the decline in the Europe & Australia segment.
- Acquisition Integration: Monitor the integration progress and financial contribution of the MECCO and Microfluidic Solutions acquisitions.
- Tariff Impact: Assess the effectiveness of pricing strategies in mitigating the impact of incremental tariffs on gross margins.
- Debt Covenants: Confirm continued compliance with the debt-to-EBITDA (0.2:1) and interest coverage (77.9:1) covenants.
- Share Repurchase Activity: Track the utilization of the remaining $78.0 million repurchase authorization.